Skip to content

Sensitivity of ECG on Detection of Three Different Intravascular Applied Test Doses of Bupivacaine and Epinephrine

Sensitivity of Electrocardiogram on Detection of Three Different Intravascular Applied Test Doses of Bupivacaine and Epinephrine: a Study in Children of Different Age

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01091766
Enrollment
150
Registered
2010-03-24
Start date
2010-03-31
Completion date
2011-07-31
Last updated
2012-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia, Toxicity

Keywords

local anaesthetics toxicity, heart arrhythmia, heart rate, heart conduction, regional anaesthesia, paediatric anaesthesia, cardio-vascular system, prevention

Brief summary

The purpose of this prospective randomised study is to investigate electrocardiographic alterations after intravascular injection of three different test solutions of bupivacaine and epinephrine in anaesthetised children up to 16 years of age.

Interventions

DRUGintravenous injection of test solution

test dose consists of 0.2 ml/kg body weight test solution of the assigned drug

Sponsors

University Children's Hospital, Zurich
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
1 Days to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 0 to 16 * healthy * parental consent

Exclusion criteria

* ASA \>1 * allergy against local anaesthetics

Design outcomes

Primary

MeasureTime frameDescription
T-wave elevation in the ECG after intravenous administration of the test solution2 minutes0.2 ml/kg test solution (bupivacaine or bupivacaine+epinephrine or epinephrine) is intravenously injected. The ECG is recorded over 2 minutes, printed and analysed later on regarding alterations of T-wave.

Secondary

MeasureTime frameDescription
Alteration in heart rate caused by intravenous injection of the test solution2 minutes0.2 ml/kg test solution (bupivacaine or bupivacaine+epinephrine or epinephrine) is intravenously injected. The ECG is recorded over 2 minutes, printed and analysed later on regarding alterations in heart rate.

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026